About: Cancer of the ovary

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cancer of the ovary Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1993

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована в листопаді 1993 (uk) article scientifique publié en 1993 (fr) im November 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 1993 (ast) scientific article published on 01 November 1993 (en)
publication date	wds:Q72356478-4402643D-D6B1-4243-8792-F9FB34C89217
publication date	1993-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72356478-0C3F8055-BED0-45C5-895D-8E91F4A81F14
language of work or name	English
cites work	wds:Q72356478-F8DA7A4A-E65F-48BA-AD0D-F60A4B642969
cites work	Reactivity of a monoclonal antibody with human ovarian carcinoma
author name string	wds:Q72356478-DCF9DEB2-326B-496D-880B-2D1F7CC554F8
author name string	Cannistra SA
rdfs:label	Cancer of the ovary (en)
skos:prefLabel	Cancer of the ovary (en)
name	Cancer of the ovary (en)
title	wds:Q72356478-A223E28D-521A-480A-8F7E-7977FCF0C7FA
title	Cancer of the ovary (en)
page(s)	wds:Q72356478-98F3A943-FBE5-42CA-8B70-AFB818803390
page(s)	1550-1559
instance of	wds:Q72356478-372d34a3-2673-4ad8-a434-cb21ff7c6bdb wds:Q72356478-92189120-235A-4FD4-B3DA-10B3D3FAF66B
instance of	review article scholarly article
PubMed ID	wds:Q72356478-9E9FA0BA-4E65-492D-B6CF-FB95F671739C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8155119
PubMed ID	8155119
published in	wds:Q72356478-ADE6DD0F-B667-4B8D-A013-D07F625A999B
published in	The New England Journal of Medicine
issue	wds:Q72356478-5D636925-7C22-4907-A126-AC96302F0FC0
volume	wds:Q72356478-1B780EF1-6392-4B69-9E51-71969354BBFA
issue	21
volume	329
DOI	wds:Q72356478-4E8B2C36-CDD2-40B0-8492-97677766488A
DOI	http://dx.doi.org/10.1056/NEJM199311183292108
DOI	10.1056/NEJM199311183292108
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72356478
is cites work of	Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer Metformin intake is associated with better survival in ovarian cancer: a case-control study Angiogenesis in epithelian ovarian cancer Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines Expression and localization of aquaporin-5 in the epithelial ovarian tumors. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. TP53 and ovarian cancer Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells Cancer stem cells as targets for cancer therapy: selected cancers as examples. A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy Expression of the thymidine phosphorylase gene in epithelial ovarian cancer Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients. Disaggregation and invasion of ovarian carcinoma ascites spheroids Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancer Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Micrometastatic bone marrow involvement: detection and prognostic significance Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma. Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma Surgical staging of cancer: Impact on prognosis and potential for bias in clinical trials Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer. Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist Nongenetic screening of ovarian malignancies Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software